Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04101357
Title Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioNTech Small Molecules GmbH
Indications

Advanced Solid Tumor

lung small cell carcinoma

Therapies

BNT411

Atezolizumab + BNT411 + Carboplatin + Etoposide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.